Michael Thomas Heneka
Michael Thomas Heneka publishes mostly in Neurology, Physiology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms and Dementia and Cognitive Impairment Research.
- World rank
- #29,361 of 7,710,434 ranked researchers
- Rank in Germany
- #1,713 of 364,343
- Works
- 587
- Citations
- 58k
- Citations per work
- 98.1
What does Michael Thomas Heneka research?
Michael Thomas Heneka's work is mostly in Medicine (25%), Neuroscience (21%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else22338.0%
- Life Sciences21736.9%
- Neuroscience12421.1%
- Biochemistry, Genetics and Molecular Biology6410.9%
- Immunology and Microbiology294.9%
- Health Sciences14725.1%
- Medicine14725.1%
- 1Neurology17% of their works
- 2Physiology16% of their works
- 3Molecular Biology11% of their works
- 4Psychiatry and Mental health9% of their works
- 5Immunology5% of their works
- 6Cognitive Neuroscience4% of their works
Research topics
- Alzheimer's disease research and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Dementia and Cognitive Impairment Research
- Tryptophan and brain disorders
- Functional Brain Connectivity Studies
- Peroxisome Proliferator-Activated Receptors
- Inflammasome and immune disorders
- Neurological Disease Mechanisms and Treatments
Which keywords describe Michael Thomas Heneka's research?
The keywords of their largest research topics: Neuroinflammation, Neurodegeneration, Oxidative Stress, Cytokines, Microglia, Amyloid Hypothesis, Tau Pathology and Astrocytes.
- Vascular Cognitive Impairment
- NLRP3
- Peroxisome Proliferator-Activated Receptors
- Resting-State fMRI
- Tryptophan Metabolism
- Inflammation
- Alzheimer's Disease
- Astrocytes
- Amyloid Hypothesis
- Cytokines
- Neurodegeneration
- Neuroinflammation
- Oxidative Stress
- Microglia
- Tau Pathology
- Synaptic Pruning
- Mild Cognitive Impairment
- Depression
- Functional Connectivity
- PPARs
- Inflammasome
- Cerebral Hypoperfusion
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Neuroinflammation5223 topics
- Neurodegeneration4552 topics
- Oxidative Stress3283 topics
- Cytokines2872 topics
- Microglia2872 topics
- Amyloid Hypothesis2351 topic
- Tau Pathology2351 topic
- Astrocytes2201 topic
- Synaptic Pruning2201 topic
- Alzheimer's Disease1341 topic
- Mild Cognitive Impairment1341 topic
- Inflammation712 topics
- Depression671 topic
- Tryptophan Metabolism671 topic
- Functional Connectivity471 topic
- Resting-State fMRI471 topic
- PPARs441 topic
- Peroxisome Proliferator-Activated Receptors441 topic
- Inflammasome271 topic
- NLRP3271 topic
- Cerebral Hypoperfusion261 topic
- Vascular Cognitive Impairment261 topic
Where does Michael Thomas Heneka work?
Michael Thomas Heneka's main affiliation in the publication record is University of Bonn, Germany.
How many publications and citations does Michael Thomas Heneka have?
OpenAlex counts 587 works and 57,572 citations for Michael Thomas Heneka, an h-index of 115, ranking #29,361 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Thomas Heneka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.